Merck
Merck & Co Inc, known as MSD outside the United States and Canada, is an American multinational biopharmaceutical corporation operating across human health and animal health sectors. The company researches, manufactures, and markets oncology immunotherapies, vaccines, cardiovascular drugs, and animal health products, led by its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. Main revenue drivers derive from global commercial sales of Keytruda oncology treatments, Gardasil vaccines, diabetes treatments, and livestock/pet pharmaceuticals. Merck & Co serves oncologists, hospital networks, government health agencies, prescription pharmacies, and veterinarians globally. The enterprise holds a world-dominant market position in immuno-oncology, cancer therapeutics, and preventive human vaccines. Headquartered in Rahway, New Jersey, Merck & Co Inc is listed on the New York Stock Exchange.
64 of the funds FundTelligence covers report a position in Merck.
- Legal name
- Merck & Co
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 64
- Exposure themes
- Multiple, Treatment, Women's Health
Funds holding Merck
- GS Global Future Health Care Equity Portfolio — Goldman Sachs · 7.65 % (largest positions only, September 2026)
- Swedbank Robur Healthcare — Swedbank · 7.08 % (full portfolio disclosed, October 2026)
- HealthInvest Sustainable Healthcare — HealthInvest · 6.4 % (partially disclosed portfolio, September 2026)
- AB International Health Care Portfolio — AllianceBernstein · 6.05 % (largest positions only, September 2026)
- BGF World Healthscience Fund — BlackRock · 5.93 % (largest positions only, October 2026)
- DNB Health Care — DNB · 5.69 % (full portfolio disclosed, September 2026)
- Fondita Healthcare — Fondita · 4.91 % (largest positions only, October 2026)
- Wellington Global Health Care Equity Fund — Wellington · 4.85 % (largest positions only, October 2026)
Showing the 8 largest of 64 funds holding it.